GLP-1 drugs, also known as GLP-1 agonists, GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs, are commonly used to treat type 2 diabetes. [1, 2]In recent years, however, healthcare providers have also been prescribing GLP-1 medication to support weight loss. Such is the ...
All GLP-1 receptor agonists like semaglutide and tirzepatide now have a warning for a rare increased risk of lung aspiration (food or liquid getting into your lungs) during deep sedation or general anesthesia used for procedures or surgery. It is thought lung aspiration may occur because these...
Thirty years later, experts seem to be asking the same thing about a new obesity intervention: glucagon-like peptide-1 (GLP-1) receptor agonists. Much like bariatric surgery in the early days, the latest generation of these injections has quickly grown in popularity, signaling a new ...
Thirty years later, experts seem to be asking the same thing about a new obesity intervention: glucagon-like peptide-1 (GLP-1) receptor agonists. Much like bariatric surgery in the early days, the latest generation of these injections has quickly grown in popularity, signaling a new ...
Both semaglutide and tirzepatide work by mimicking the hormone, GLP-1 (glucagon-like peptide one), to manage hunger and slow down digestion. Tirzepatide - Mounjaro - is a dual-acting drug and also mimics the hormone GIP (glucose-dependent insulinotropic polypeptide). ...
Can GLP-1 Weight Loss Drugs Help Treat Menopause Weight Gain?Medically ReviewedbyAdam Gilden, MD, MSCE|November 15, 2024 menopause Women Taking Hormone Therapy for Menopause Symptoms Can Stay on It for DecadesPublished onSeptember 10, 2024 menopause Hormone Therapy May Slow Biological Aging in Olde...
Ozempic (semaglutide injections) Rybelsus (oral semaglutide – the only oral GLP-1 agonist) Side effects of GLP-1 agonists include weight loss and nausea [2]. GLP-1 agonists have been associated with asymptomatic pancreatitis and pancreatic cancer in limited studies, but this association is sti...
GLP-1 receptor agonists and SGLT-2is were found to exert striking benefits on the heart, liver, kidney, and even the brain [34,35,36,37,38,39,40]. Emerging research indicates that these benefits are conferred by pleiotropic mechanisms, that is, pathways distinct from those involved in gluc...
Tirzepatide targets GLP-1, but also affects a second hormone, called GIP, which developers say contributes to its increased effectiveness. Mounjaro was approved to treat diabetes in May 2022. The drugs are delivered through once-weekly injections. Users are advised to follow a healthful, reduce...
“Ozempic face” is a nonmedical term that refers to the gaunt appearance in the face that can happen when someone loses weight quickly, specifically while taking a GLP-1 drug such as Ozempic. The rapid loss of fat from the face is the cause of the hollowed cheeks and looser skin. ...